Cardiac Ablation Market Revenue to Cross US$ 6.5 Bn by 2026: Global Market Insights, Inc.

SELBYVILLE, Del., February 6, 2020 (Newswire.com) - ​​​Global Market Insights, Inc. has recently added a new report on the cardiac ablation devices market which estimates the global market valuation for cardiac ablation will cross US$ 6.5 billion by 2026. Technological advancements and new product development in the cardiac ablation market will offer lucrative opportunities for industry expansion in the foreseeable future. To offer effective treatment methods to patients, major market players are advancing ablation technologies to increase customer preference towards cardiac ablation.

A rising geriatric population and increasing multitude of cardiological disorders worldwide will result in a significant number of patients requiring cardiac ablation procedures. According to the Centers for Disease Control and Prevention, one person dies every second from some form of cardiovascular disorder in the U.S. Certain disorders cannot be mitigated through drug therapy alone, therefore cardiac ablation procedures are being rapidly adopted for they provide faster recovery and better outcomes.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3702

Some major findings of the cardiac ablation technologies market report include:

1)        Increasing number of patients suffering from cardiovascular diseases including cardiac arrhythmias.

2)        Rising demand for minimally invasive procedures.

3)        Technological advancements in cardiac ablation devices.

Ultrasound ablators segment will witness a lucrative 14% CAGR during the forecast period. Ultrasound ablators are easy-to-use and widely used for intracardiac visualization of cardiac physiology. Thus, wide adoption of advanced ultrasound ablators due to its cost-effective nature, rising awareness and increasing healthcare expenditure for the improved healthcare facilities will augment the segmental growth.

Other applications of the cardiac ablation devices market accounted for substantial revenue of over USD 117 million in 2019. The increasing incidence of chronic disorders such as valve diseases, coronary artery disease and rheumatoid heart disease will positively influence cardiac ablation market. Cardiac ablation procedures are used during repair of the heart valves that are damaged by rheumatic fever. Also, the procedure also correct arrhythmias occurring due to rheumatoid heart disease, thus augmenting market growth.

Demand for ablation procedure in ambulatory surgical centers will witness rapid growth during the analysis period. Growing demand is contributed by advanced healthcare facilities and increasing cases of chronic disease worldwide. Moreover, presence of specialized doctors, high-end infrastructure, quick procedure length and easy accessibility, especially in developed countries will further boost segmental growth.

Browse key industry insights spread across 151 pages with 252 market data tables & 12 figures & charts from the report, “Cardiac Ablation Market Share & Forecast, 2020 – 2026” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/cardiac-ablation-market

Germany's cardiac ablation market is poised to witness 12.7% CAGR during the analysis period. Rising prevalence of cardiovascular diseases and rising awareness among the population regarding advanced medical facilities will foster industry growth. Moreover, Germany is one of the most developed countries in terms of economy and technologies, which will favor robust industry growth. Major market players have established their presence by acquiring domestic companies, that will play a vital role in influencing the market growth.

Some major findings of the cardiac ablation market report include:

• A growing geriatric population pool coupled with an increased incidence of cardiovascular diseases (CVDs) resulting in high incidence rate will drive the adoption of cardiac ablation in developed and developing nations.
   
• Growing awareness about advanced treatment options for CVDs in the market will offer expansion opportunities.
   
• Mounting number of atrial fibrillation patients worldwide will significantly increase the demand for cardiac ablation.

Major players operating in the cardiac ablation devices industry include Medtronic plc, Abbott Laboratories (St. Jude Medical), Boston Scientific Corporation, and Stereotaxis, Inc. among other players. Industry players are implementing various strategies such as product innovations and partnerships to gain competitive advantage for business expansion.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3702

Partial chapters of report table of contents (TOC):

Chapter 3. Cardiac Ablation Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 – 2026

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.2.  Industry pitfalls and challenges

3.3.2.1.  High risk associated with cardiac ablation procedures

3.3.2.2.  Stringent regulatory scenario

3.4. Growth potential analysis

3.4.1.  By product

3.4.2.  By application

3.4.3.  By end-use

3.5. Regulatory landscape

3.5.1.  U.S.

3.5.2.  Europe

3.6. Porter’s analysis

3.7. Number of cardiac ablation procedures, by type

3.7.1.  Atrial ablation

3.7.1.1.    Market size, by region, 2015–2026 (Number of procedures)

3.7.1.1.1. North America market size, by disease, 2015–2026 (Number of procedures)

3.7.1.1.2.   Europe market size, by disease, 2015–2026 (Number of procedures)

3.7.1.1.3.   Asia Pacific market size, by disease, 2015–2026 (Number of procedures)

3.7.1.1.4.   Latin America market size, by disease, 2015–2026 (Number of procedures)

3.7.1.1.5.   MEA market size, by disease, 2015–2026 (Number of procedures)

3.7.2.  Ventricular ablation

3.7.2.1.    Market size, by region, 2015–2026 (Number of procedures)

3.7.2.1.1. North America market size, by disease, 2015–2026 (Number of procedures)

3.7.2.1.2.   Europe market size, by disease, 2015–2026 (Number of procedures)

3.7.2.1.3.   Asia Pacific market size, by disease, 2015–2026 (Number of procedures)

3.7.2.1.4.   Latin America market size, by disease, 2015–2026 (Number of procedures)

3.7.2.1.5.   MEA market size, by disease, 2015–2026 (Number of procedures)

3.8. Competitive landscape, 2019

3.9. PESTEL analysis

Browse complete report table of contents @ https://www.gminsights.com/toc/detail/cardiac-ablation-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

Source: Global Market Insights Inc.